A Study to Assess the Efficacy of Public Health Campaigns in Reducing Lead Exposure
1 other identifier
interventional
400
1 country
1
Brief Summary
This clinical trial aims to evaluate the effectiveness of targeted public health campaigns in reducing lead exposure among adults living in urban communities with known environmental lead hazards. Lead exposure remains a significant public health concern, particularly in older urban neighborhoods with aging infrastructure and legacy contamination. Despite existing regulations and remediation efforts, many communities continue to experience elevated blood lead levels, especially among vulnerable populations. The study will compare the impact of an intensive, multi-modal public health campaign-featuring community workshops, educational materials, and home intervention resources-against standard municipal information dissemination. By assessing changes in blood lead levels and lead-related knowledge, attitudes, and behaviors over a 12-month period, the trial seeks to determine whether enhanced public health outreach can more effectively reduce lead exposure and promote safer practices. The findings will inform future strategies for community-based environmental health interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 27, 2026
CompletedFirst Posted
Study publicly available on registry
June 8, 2026
CompletedStudy Start
First participant enrolled
October 31, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2028
Study Completion
Last participant's last visit for all outcomes
November 1, 2028
June 8, 2026
June 1, 2026
2 years
May 27, 2026
June 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Blood Lead Level
Mean change in venous blood lead concentration (μg/dL) among index household participants from baseline to 12 months.
Through study completion, an average of 1 year
Secondary Outcomes (4)
Change in Lead-Related Knowledge
Through study completion, an average of 1 year
Adoption of Lead-Safe Practices
Through study completion, an average of 1 year
Environmental Lead Levels in Home
Through study completion, an average of 1 year
Incidence of New Elevated Blood Lead Cases
Through study completion, an average of 1 year
Study Arms (2)
Intensive Public Health Campaign
EXPERIMENTALParticipants receive an intensive, multi-modal public health campaign including workshops, educational materials, lead-safe cleaning kits, and home visits by health educators.
Standard Information Dissemination
ACTIVE COMPARATORParticipants receive the standard municipal information package on lead exposure prevention currently distributed by city health departments.
Interventions
A comprehensive intervention including: (1) three interactive community workshops on lead risks and prevention, (2) distribution of tailored educational materials, (3) provision of lead-safe cleaning kits (HEPA vacuums, cleaning supplies), and (4) two home visits by trained health educators to reinforce messages and assess household practices. Delivered over a 12-month period.
Provision of standard municipal information on lead exposure prevention, including pamphlets and website links, as currently distributed by public health authorities. No additional workshops or home visits provided.
Eligibility Criteria
You may qualify if:
- Resident of selected urban neighborhoods with documented environmental lead risk
- Household includes at least one adult aged 18-75 years willing to participate
- Willing to provide informed consent
- Willing to allow home visits and blood sampling
- Able to understand study procedures and interventions
You may not qualify if:
- Planning to relocate from the area within the next 12 months
- Household member with a known diagnosis of severe anemia or bleeding disorder
- Participation in another intervention study targeting lead exposure in the past 12 months
- Inability or unwillingness to comply with study procedures
- Household with known ongoing lead remediation efforts during the study period
- Pregnant women (due to additional ethical considerations for blood sampling)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Philadelphia City Center
Philadelphia, Pennsylvania, 19107, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Brian Goldstein, MD MPH
International Health Strategies LLC
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Open-label due to the nature of behavioral and educational interventions.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 27, 2026
First Posted
June 8, 2026
Study Start (Estimated)
October 31, 2026
Primary Completion (Estimated)
November 1, 2028
Study Completion (Estimated)
November 1, 2028
Last Updated
June 8, 2026
Record last verified: 2026-06